Association between dipeptidyl peptidase-4 inhibitors use and leptin in type 2 diabetes mellitus

Association between dipeptidyl peptidase-4 inhibitors use and leptin in type 2 diabetes mellitus

Abstract Background Dipeptidyl peptidase-4 inhibitors (DPP-4i) provide a unique antihyperglycemic effect by regulating incretin peptides in type 2 diabetes mellitus (T2DM) patients who are inadequately controlled with insulin therapy. The aim of this study was to investigate the impact of DPP-4i on...

Full description

Bibliographic Details
Main Authors: Xin Wei, Yu Bai, Zhuo Wang, Xiaohong Zheng, Zening Jin, Xin Liu
Format: Article
Language:English
Published: BMC 2021-08-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Dipeptidyl peptidase-4 inhibitors
Leptin
Type 2 diabetes mellitus
Randomized controlled trials
Online Access:https://doi.org/10.1186/s13098-021-00703-x

Similar Items

Similar Items